bf/NASDAQ:UTRS_icon.png

NASDAQ:UTRS

Minerva Surgical, Inc.

  • Stock

USD

Market Cap

13.14M

Beta: -

Volume Today

1

Avg: 322.31K

PE Ratio

−0.20

PFCF: −0.18

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
net income
-52.05M
-
-18.26M
64.91%
-21.46M
17.53%
-34.11M
58.93%
depreciation and amortization
1.68M
-
7.08M
322.45%
10.62M
50.08%
10.81M
1.75%
deferred income tax
14.95M
-
-132K
100.88%
-19.42M
14,612.12%
stock based compensation
587K
-
858K
46.17%
6.82M
694.52%
6.98M
2.36%
change in working capital
-2.11M
-
-2.87M
35.59%
-8.55M
198.39%
-11.05M
29.29%
accounts receivables
-332K
-
-4.43M
1,234.94%
1.09M
124.53%
48K
95.58%
inventory
835K
-
1.26M
51.38%
-9.07M
817.72%
-4.13M
54.42%
accounts payables
-2.98M
-
-687K
76.98%
3.30M
580.35%
-881K
126.70%
other working capital
368K
-
990K
169.02%
-3.86M
490.30%
-6.08M
57.48%
other non cash items
17.16M
-
1.08M
93.68%
9.62M
786.36%
-8.19M
185.12%
net cash provided by operating activities
-19.79M
-
-12.24M
38.15%
-22.38M
82.82%
-35.57M
58.93%
investments in property plant and equipment
-223K
-
-453K
103.14%
-584K
28.92%
-73K
87.50%
acquisitions net
-15M
-
purchases of investments
sales maturities of investments
other investing activites
-25M
-
net cash used for investing activites
-223K
-
-15.45M
6,829.60%
-25.58M
65.56%
-73K
99.71%
debt repayment
-9.05M
-
-35.38M
-
common stock issued
110K
-
118K
7.27%
70.72M
59,836.44%
36K
99.95%
common stock repurchased
dividends paid
other financing activites
52.10M
-
17.96M
65.53%
35.86M
99.69%
-5M
113.94%
net cash used provided by financing activities
43.16M
-
18.08M
58.11%
71.21M
293.94%
-4.96M
106.97%
effect of forex changes on cash
net change in cash
23.14M
-
-9.62M
141.56%
23.25M
341.75%
-40.60M
274.65%
cash at beginning of period
11.64M
-
34.78M
198.75%
25.17M
27.65%
48.41M
92.38%
cash at end of period
34.78M
-
25.17M
27.65%
48.41M
92.38%
7.81M
83.87%
operating cash flow
-19.79M
-
-12.24M
38.15%
-22.38M
82.82%
-35.57M
58.93%
capital expenditure
-223K
-
-453K
103.14%
-584K
28.92%
-73K
87.50%
free cash flow
-20.02M
-
-12.69M
36.58%
-22.96M
80.90%
-35.64M
55.21%

All numbers in USD (except ratios and percentages)